Galectin Therapeutics
GALT
#9132
Rank
NZ$0.14 B
Marketcap
$2.36
Share price
3.13%
Change (1 day)
-52.61%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$1.08

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.18. In 2022 the company made an earnings per share (EPS) of -$1.16 a decrease over its 2021 EPS that were of -$0.93.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.08-7.21%
2022-$1.1625%
2021-$0.9330%
2020-$0.71-6.98%
2019-$0.7713.16%
2018-$0.68-22.45%
2017-$0.88-35.53%
2016-$1.36-13.64%
2015-$1.5711.39%
2014-$1.41-39.69%
2013-$2.3481.94%
2012-$1.29-32.08%
2011-$1.897.07%
2010-$1.77-17.5%
2009-$2.14150%
2008-$0.86-68%
2007-$2.68127.27%
2006-$1.18-52.17%
2005-$2.47-20.69%
2004-$3.1152.63%
2003-$2.04-13.64%
2002-$2.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$22.91 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.34-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA